RIKER LAUREN

CIK 00015454391 companyBRISBANE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001545439

Recent Transactions

50 trades

Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2026-02-11+19,273→ 71,586.242 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2026-02-02$20.81/sh−4,000→ 52,313.242 total
Tax Payment
Pacira BioSciences, Inc.$PCRX
Common Stock
2026-01-30$20.54/sh−2,751→ 56,313.242 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2026-01-05$24.24/sh−1,416→ 59,064.242 total
Tax Payment
Pacira BioSciences, Inc.$PCRX
Common Stock
2026-01-02$24.46/sh−159→ 60,480.242 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2025-06-04$26.21/sh−5,578.335→ 59,564 total
Tax Payment
Pacira BioSciences, Inc.$PCRX
Common Stock
2025-06-03$26.40/sh−3,374→ 65,142.335 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2025-02-01+30,600→ 68,516.335 total
Tax Payment
Pacira BioSciences, Inc.$PCRX
Common Stock
2025-01-02$18.33/sh−159→ 37,916.335 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2024-06-12$28.72/sh−3,970→ 38,075.335 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2024-06-12+21,360→ 42,045.335 total
Tax Payment
Pacira BioSciences, Inc.$PCRX
Common Stock
2024-06-03$30.89/sh−1,843→ 20,685.335 total
Tax Payment
Pacira BioSciences, Inc.$PCRX
Common Stock
2024-01-02$32.00/sh−159→ 22,528.335 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-07-05$38.91/sh−643→ 22,687.335 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-06-14$39.01/sh−7→ 22,687 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-06-14$38.52/sh−5,773→ 22,694 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-06-14+10,000→ 29,053 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-06-14$37.47/sh−586→ 28,467 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2023-06-14+25,000→ 25,000 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-06-07$37.87/sh−616→ 19,053 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-06-06$38.99/sh−591→ 19,669 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-06-08+14,600→ 14,600 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-06-08+5,850→ 19,852 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-06-06$61.37/sh−1,150→ 14,002 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-03-10$71.14/sh−8,400→ 16,052 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-03-10$71.95/sh−900→ 15,152 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-03-10−9,300→ 0 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-03-10$10.81/sh+9,300→ 24,452 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-01-18−2,500→ 9,300 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-01-18$64.97/sh−2,500→ 15,152 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-01-18$10.81/sh+2,500→ 17,652 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-01-04+5,000→ 5,000 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-01-04+2,000→ 15,152 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-07-29$60.81/sh−90→ 13,152 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2021-07-29−90→ 11,800 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-07-29$10.81/sh+90→ 13,242 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-07-28$10.81/sh+2,410→ 15,562 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-07-28$60.85/sh−2,410→ 13,152 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2021-07-28−2,410→ 11,890 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-06-11$59.85/sh−2,003→ 12,731 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2021-06-09+6,500→ 6,500 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-06-09+2,600→ 14,734 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-06-04$61.04/sh−1,047→ 12,134 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-03-17$70.01/sh−2,000→ 13,181 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-03-17$10.81/sh+2,000→ 15,181 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2021-03-17−2,000→ 14,300 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2021-03-15−1,520→ 16,300 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-03-15$10.81/sh+1,520→ 14,701 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-03-15$73.28/sh−1,520→ 13,181 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2020-11-13−3,000→ 17,820 total

Companies

Pacira BioSciences, Inc.
Senior Vice President, Finance
$PCRX

Recent Filings

Address

C/O PACIRA BIOSCIENCES, INC. 2000 SIERRA POINT PARKWAY, SUITE 900

BRISBANE, CA, 94005

View on SEC.gov